• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑癌基因 LKB1 通过磷酸化 Yap 调控 AMPK/mTOR 非依赖的细胞生长和增殖。

LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap.

机构信息

Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

出版信息

Oncogene. 2013 Aug 29;32(35):4100-9. doi: 10.1038/onc.2012.431. Epub 2012 Oct 1.

DOI:10.1038/onc.2012.431
PMID:23027127
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3977597/
Abstract

The liver kinase B1 (LKB1) tumor suppressor inhibits cell growth through its regulation of cellular metabolism and apical-basal polarity. The best understood mechanism whereby LKB1 limits cell growth is through activation of the AMP-activated-protein-kinase/mammalian-target-of-rapamycin (AMPK/mTOR) pathway to control metabolism. As LKB1 is also required for polarized epithelial cells to resist hyperplasia, it is anticipated to function through additional mechanisms. Recently, Yes-associated protein (Yap) has emerged as a transcriptional co-activator that modulates tissue homeostasis in response to cell-cell contact. Thus this study examined a possible connection between Yap and LKB1. Restoration of LKB1 expression in HeLa cells, which lack this tumor suppressor, or short-hairpin RNA knockdown of LKB1 in NTERT immortalized keratinocytes, demonstrated that LKB1 promotes Yap phosphorylation, nuclear exclusion and proteasomal degradation. The ability of phosphorylation-defective Yap mutants to rescue LKB1 phenotypes, such as reduced cell proliferation and cell size, suggest that Yap inhibition contributes to LKB1 tumor suppressor function(s). However, failure of Lats1/2 knockdown to suppress LKB1-mediated Yap regulation suggested that LKB1 signals to Yap via a non-canonical pathway. Additionally, LKB1 inhibited Yap independently of either AMPK or mTOR activation. These findings reveal a novel mechanism whereby LKB1 may restrict cancer cell growth via the inhibition of Yap.

摘要

肝激酶 B1(LKB1)肿瘤抑制因子通过调节细胞代谢和顶端-基底极性来抑制细胞生长。LKB1 限制细胞生长的最佳理解机制是通过激活 AMP 激活蛋白激酶/哺乳动物雷帕霉素靶蛋白(AMPK/mTOR)途径来控制代谢。由于 LKB1 对于极化上皮细胞抵抗增生也是必需的,因此预计它将通过其他机制发挥作用。最近,Yes 相关蛋白(Yap)已成为一种转录共激活因子,可响应细胞间接触来调节组织稳态。因此,本研究检查了 Yap 和 LKB1 之间可能存在的联系。在缺乏这种肿瘤抑制因子的 HeLa 细胞中恢复 LKB1 的表达,或在 NTERT 永生化角质形成细胞中用短发夹 RNA 敲低 LKB1,证明 LKB1 促进 Yap 磷酸化、核排斥和蛋白酶体降解。磷酸化缺陷的 yap 突变体能够拯救 LKB1 表型,如降低细胞增殖和细胞大小,这表明 yap 抑制有助于 LKB1 肿瘤抑制因子的功能。然而,Lats1/2 敲低未能抑制 LKB1 介导的 yap 调节表明,LKB1 通过非经典途径向 yap 发出信号。此外,LKB1 抑制 yap 不依赖于 AMPK 或 mTOR 的激活。这些发现揭示了一种新的机制,即 LKB1 可能通过抑制 yap 来限制癌细胞的生长。

相似文献

1
LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap.抑癌基因 LKB1 通过磷酸化 Yap 调控 AMPK/mTOR 非依赖的细胞生长和增殖。
Oncogene. 2013 Aug 29;32(35):4100-9. doi: 10.1038/onc.2012.431. Epub 2012 Oct 1.
2
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.和厚朴酚通过 LKB1 依赖途径激活乳腺癌细胞中的 AMP 激活的蛋白激酶并抑制乳腺癌发生。
Breast Cancer Res. 2012 Feb 21;14(1):R35. doi: 10.1186/bcr3128.
3
Energy stress regulates hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein.能量应激通过AMPK介导的血管动蛋白样1蛋白调节来调控河马-YAP信号通路。
Cell Rep. 2014 Oct 23;9(2):495-503. doi: 10.1016/j.celrep.2014.09.036. Epub 2014 Oct 16.
4
Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases.血清剥夺通过 LATS1/2 蛋白激酶磷酸化 Angiomotin 的 130kDa 同工型抑制转录共激活因子 YAP 和细胞生长。
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17368-73. doi: 10.1073/pnas.1308236110. Epub 2013 Oct 7.
5
Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase-mediated inhibitory phosphorylation of the transcriptional coactivator YAP.钙调蛋白通过促进 LATS1 激酶介导的转录共激活因子 YAP 的抑制性磷酸化来激活 Hippo 信号通路。
J Biol Chem. 2022 May;298(5):101839. doi: 10.1016/j.jbc.2022.101839. Epub 2022 Mar 17.
6
Tumor suppressor LATS1 is a negative regulator of oncogene YAP.肿瘤抑制因子LATS1是致癌基因YAP的负调控因子。
J Biol Chem. 2008 Feb 29;283(9):5496-509. doi: 10.1074/jbc.M709037200. Epub 2007 Dec 24.
7
Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway.细胞能量应激诱导AMPK介导的YAP和Hippo信号通路调控。
Nat Cell Biol. 2015 Apr;17(4):500-10. doi: 10.1038/ncb3111. Epub 2015 Mar 9.
8
Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.肿瘤抑制因子LKB1、STRADα/β和MO25α/β之间的复合物是AMP激活的蛋白激酶级联反应中的上游激酶。
J Biol. 2003;2(4):28. doi: 10.1186/1475-4924-2-28. Epub 2003 Sep 24.
9
Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.血管生成素刺激 LATS 激酶自身磷酸化,并作为支架促进 Hippo 信号通路。
J Biol Chem. 2018 Nov 23;293(47):18230-18241. doi: 10.1074/jbc.RA118.004187. Epub 2018 Sep 28.
10
Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.大肿瘤抑制同源物1和2通过拮抗共激活因子YAP和TAZ来调节小鼠肝祖细胞的增殖和成熟。
Hepatology. 2016 Nov;64(5):1757-1772. doi: 10.1002/hep.28768. Epub 2016 Sep 30.

引用本文的文献

1
Comprehensively Testing the Function of Missense Variation in the Tumour Suppressor.全面测试肿瘤抑制因子中错义变异的功能。
bioRxiv. 2025 Jul 18:2025.07.14.664734. doi: 10.1101/2025.07.14.664734.
2
Evaluating predictors of kinase activity of STK11 variants identified in primary human non-small cell lung cancers.评估在原发性人类非小细胞肺癌中鉴定出的STK11变体激酶活性的预测因子。
Hum Genet. 2025 Mar;144(2-3):127-142. doi: 10.1007/s00439-025-02726-0. Epub 2025 Feb 12.
3
Yap methylation-induced FGL1 expression suppresses anti-tumor immunity and promotes tumor progression in KRAS-driven lung adenocarcinoma.Yap 甲基化诱导的 FGL1 表达抑制了 KRAS 驱动的肺腺癌中的抗肿瘤免疫并促进了肿瘤进展。
Cancer Commun (Lond). 2024 Nov;44(11):1350-1373. doi: 10.1002/cac2.12609. Epub 2024 Sep 28.
4
Evaluating predictors of kinase activity of STK11 variants identified in primary human non-small cell lung cancers.评估在原发性人类非小细胞肺癌中鉴定出的STK11变体激酶活性的预测因子。
Res Sq. 2024 Jul 2:rs.3.rs-4587317. doi: 10.21203/rs.3.rs-4587317/v1.
5
STK11 loss leads to YAP1-mediated transcriptional activation in human KRAS-driven lung adenocarcinoma cell lines.STK11 缺失导致 YAP1 介导的转录激活在人类 KRAS 驱动的肺腺癌细胞系中。
Cancer Gene Ther. 2024 Jan;31(1):1-8. doi: 10.1038/s41417-023-00687-y. Epub 2023 Nov 15.
6
Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.非河马激酶:在YAP/TAZ信号传导中的不可或缺作用及在癌症治疗中的意义
Mol Biol Rep. 2023 May;50(5):4565-4578. doi: 10.1007/s11033-023-08329-0. Epub 2023 Mar 6.
7
PTEN and LKB1 are differentially required in Gli1-expressing mesenchymal cells to suppress gastrointestinal polyposis.PTEN 和 LKB1 在表达 Gli1 的间质细胞中存在差异需求,以抑制胃肠道息肉形成。
Cell Rep. 2022 Jul 19;40(3):111125. doi: 10.1016/j.celrep.2022.111125.
8
Hippo signalling in the liver: role in development, regeneration and disease.肝脏中的 Hippo 信号通路:在发育、再生和疾病中的作用。
Nat Rev Gastroenterol Hepatol. 2022 May;19(5):297-312. doi: 10.1038/s41575-021-00571-w. Epub 2022 Jan 21.
9
Functional assessment of somatic STK11 variants identified in primary human non-small cell lung cancers.原发非小细胞肺癌中鉴定的体细胞 STK11 变异的功能评估。
Carcinogenesis. 2021 Dec 31;42(12):1428-1438. doi: 10.1093/carcin/bgab104.
10
Regulatory Mechanisms of LncRNAs in Cancer Glycolysis: Facts and Perspectives.长链非编码RNA在肿瘤糖酵解中的调控机制:现状与展望
Cancer Manag Res. 2021 Jul 5;13:5317-5336. doi: 10.2147/CMAR.S314502. eCollection 2021.

本文引用的文献

1
Deregulated MYC expression induces dependence upon AMPK-related kinase 5.去调控的 MYC 表达会诱导对 AMPK 相关激酶 5 的依赖性。
Nature. 2012 Mar 28;483(7391):608-12. doi: 10.1038/nature10927.
2
Integrating developmental signals: a Hippo in the (path)way.整合发育信号: Hippo 在(路径)中。
Oncogene. 2012 Apr 5;31(14):1743-56. doi: 10.1038/onc.2011.363. Epub 2011 Aug 29.
3
Hippo pathway regulation by cell morphology and stress fibers.Hippo 通路受细胞形态和应激纤维的调节。
Development. 2011 Sep;138(18):3907-14. doi: 10.1242/dev.070987. Epub 2011 Aug 10.
4
Role of YAP/TAZ in mechanotransduction.YAP/TAZ 在机械转导中的作用。
Nature. 2011 Jun 8;474(7350):179-83. doi: 10.1038/nature10137.
5
A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription.一种基于细胞的 Hippo 通路激活剂筛选检测方法显示,多巴酚丁胺对 YAP 依赖性基因转录有抑制作用。
J Biochem. 2011 Aug;150(2):199-208. doi: 10.1093/jb/mvr063. Epub 2011 May 17.
6
Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer.非小细胞肺癌中 LKB1/STK11 基因的频繁纯合缺失。
Oncogene. 2011 Sep 1;30(35):3784-91. doi: 10.1038/onc.2011.98. Epub 2011 May 2.
7
Yap1 acts downstream of α-catenin to control epidermal proliferation.Yap1 在 α-连环蛋白下游发挥作用,控制表皮细胞增殖。
Cell. 2011 Mar 4;144(5):782-95. doi: 10.1016/j.cell.2011.02.031.
8
The adaptor protein AMOT promotes the proliferation of mammary epithelial cells via the prolonged activation of the extracellular signal-regulated kinases.衔接蛋白 AMOT 通过延长细胞外信号调节激酶的激活促进乳腺上皮细胞的增殖。
Cancer Res. 2011 Mar 15;71(6):2203-11. doi: 10.1158/0008-5472.CAN-10-1995. Epub 2011 Feb 1.
9
The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling.通往合理治疗与 LKB1/AMPK/TSC/mTORC1 信号相关的癌症的漫长曲折之路。
Oncogene. 2011 May 19;30(20):2289-303. doi: 10.1038/onc.2010.630. Epub 2011 Jan 24.
10
The hippo signaling pathway in development and cancer.河马信号通路在发育和癌症中的作用。
Dev Cell. 2010 Oct 19;19(4):491-505. doi: 10.1016/j.devcel.2010.09.011.